Literature DB >> 20871124

Excess lung function decline in gold miners following pulmonary tuberculosis.

J Ross1, R I Ehrlich, E Hnizdo, N White, G J Churchyard.   

Abstract

BACKGROUND: Few if any studies of the association between pulmonary tuberculosis (TB) and lung function loss have had access to premorbid lung function values.
METHODS: Using a retrospective cohort design, the study recruited employed South African gold miners who had undergone a pulmonary function test (PFT) between January 1995 and August 1996. The 'exposed' group comprised 185 miners treated for pulmonary TB after the initial PFT and the 'unexposed' group comprised 185 age-matched miners without TB. All participants had a follow-up PFT between April and June 2000. The outcome of interest was decline in lung function during the follow-up period as measured by forced vital capacity (FVC) and forced expiratory volume in 1 s(FEV(1)).
RESULTS: After controlling for age, height, baseline lung function, silicosis, years of employment, smoking and other respiratory diagnoses, pulmonary TB during the follow-up period was associated with a mean excess loss of 40.3 ml/year in FEV(1) (95% CI 25.4 to 55.1) and 42.7 ml/year in FVC (95% CI 27.0 to 58.5). Lung function loss was greater among those with more severe or later clinical presentation of TB. Breathlessness was twice as common among TB cases (OR 2.20, 95% CI 1.18 to 4.11).
CONCLUSION: There is a need for greater clinical recognition of the long-term respiratory consequences of treated pulmonary TB. Early detection of TB would help to reduce these sequelae and remains a priority, particularly in a workforce already subject to silica dust disease. However, strategies such as dust control, worker education about TB and dust and TB preventive therapy are also needed to avert the disease itself.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20871124     DOI: 10.1136/thx.2009.129999

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  25 in total

1.  Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis.

Authors:  David W Denning; Alex Pleuvry; Donald C Cole
Journal:  Bull World Health Organ       Date:  2011-09-27       Impact factor: 9.408

2.  Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Mi-Sun Koo; Blas Peixoto; Dorothy Fallows; Jerome B Zeldis; George Muller; Gilla Kaplan
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

3.  Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis.

Authors:  Shruthi Ravimohan; Sara C Auld; Pholo Maenetje; Nelly Ratsela; Mandla Mlotshwa; Itai Ncube; Jonathan P Smith; Mboyo-Di-Tamba Vangu; Modulakgotla Sebe; Andrew Kossenkov; Drew Weissman; Robert S Wallis; Gavin Churchyard; Hardy Kornfeld; Gregory P Bisson
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

Review 4.  Host-directed immunotherapy of viral and bacterial infections: past, present and future.

Authors:  Robert S Wallis; Anne O'Garra; Alan Sher; Andreas Wack
Journal:  Nat Rev Immunol       Date:  2022-06-07       Impact factor: 108.555

5.  Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

Authors:  G B Migliori; F M Marx; N Ambrosino; E Zampogna; H S Schaaf; M M van der Zalm; B Allwood; A L Byrne; K Mortimer; R S Wallis; G J Fox; C C Leung; J M Chakaya; B Seaworth; A Rachow; B J Marais; J Furin; O W Akkerman; F Al Yaquobi; A F S Amaral; S Borisov; J A Caminero; A C C Carvalho; D Chesov; L R Codecasa; R C Teixeira; M P Dalcolmo; S Datta; A-T Dinh-Xuan; R Duarte; C A Evans; J-M García-García; G Günther; G Hoddinott; S Huddart; O Ivanova; R Laniado-Laborín; S Manga; K Manika; A Mariandyshev; F C Q Mello; S G Mpagama; M Muñoz-Torrico; P Nahid; C W M Ong; D J Palmero; A Piubello; E Pontali; D R Silva; R Singla; A Spanevello; S Tiberi; Z F Udwadia; M Vitacca; R Centis; L D Ambrosio; G Sotgiu; C Lange; D Visca
Journal:  Int J Tuberc Lung Dis       Date:  2021-10-01       Impact factor: 3.427

Review 6.  Convergence of non-communicable diseases and tuberculosis: a two-way street?

Authors:  M J Magee; A D Salindri; U P Gujral; S C Auld; J Bao; J S Haw; H-H Lin; H Kornfeld
Journal:  Int J Tuberc Lung Dis       Date:  2018-11-01       Impact factor: 2.373

7.  The association between airflow obstruction and radiologic change by tuberculosis.

Authors:  Yong Il Hwang; Joo Hee Kim; Chang Youl Lee; Sunghoon Park; Yong Bum Park; Seung Hun Jang; Cheol Hong Kim; Tae Rim Shin; Sang Myun Park; Yun Su Sim; Dong-Gyu Kim; Myung-Goo Lee; In-Gyu Hyun; Ki-Suck Jung
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

8.  Tuberculosis associates with both airflow obstruction and low lung function: BOLD results.

Authors:  André F S Amaral; Sonia Coton; Bernet Kato; Wan C Tan; Michael Studnicka; Christer Janson; Thorarinn Gislason; David Mannino; Eric D Bateman; Sonia Buist; Peter G J Burney
Journal:  Eur Respir J       Date:  2015-06-25       Impact factor: 16.671

9.  Prevalence Characteristics of Coal Workers' Pneumoconiosis (CWP) in a State-Owned Mine in Eastern China.

Authors:  Lei Han; Ruhui Han; Xiaoming Ji; Ting Wang; Jingjin Yang; Jiali Yuan; Qiuyun Wu; Baoli Zhu; Hengdong Zhang; Bangmei Ding; Chunhui Ni
Journal:  Int J Environ Res Public Health       Date:  2015-07-10       Impact factor: 3.390

Review 10.  Platelet Activation and the Immune Response to Tuberculosis.

Authors:  Daniela E Kirwan; Deborah L W Chong; Jon S Friedland
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.